Daily Target 2X Long MRNA ETF (MRNX) Stock Overview
Explore Daily Target 2X Long MRNA ETF’s financial performance, market position, analyst ratings, and future outlook.
Daily Target 2X Long MRNA ETF (MRNX)
Key Financials
Key Financials
Market Cap
5.9M
P/E Ratio
N/A
EPS (TTM)
N/A
ROE
0.00%
MRNX Stock Analysis & Investment Overview (AMEX)
Our AI-powered analysis of Daily Target 2X Long MRNA ETF (AMEX: MRNX) gives investors deep insight into how the stock performs on the AMEX exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Daily Target 2X Long MRNA ETF's AMEX-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of MRNX on the AMEX shows an RSI of 91.46, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $36.23 for the AMEX listing.
Key metrics behind Daily Target 2X Long MRNA ETF's AMEX-traded stock include a P/E ratio of N/A and a market capitalization of 5.9M. Combined with our AI analysis, these give both institutional and retail investors a clear view of MRNX on the AMEX.